Device type · JHX
Fluorometric Method, Cpk Or Isoenzymes
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JHX
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
2
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Fluorometric Method, Cpk Or Isoenzymes
- Product code
- JHX
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1215
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JHX
Latest FDA decisions
- Access CK-MB510(k)
K234005 · Decided Feb 16, 2024 · 59 days after receipt
Device type: Fluorometric Method, Cpk Or Isoenzymes (JHX) · Laboratory Medicine & Pathology
K212648 · Decided Jan 28, 2022 · 158 days after receipt
Device type: Fluorometric Method, Cpk Or Isoenzymes (JHX) · Laboratory Medicine & Pathology
K163462 · Decided Sep 21, 2017 · 286 days after receipt
Device type: Fluorometric Method, Cpk Or Isoenzymes (JHX) · Laboratory Medicine & Pathology
Reports received
2
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
2
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results1
- Low Test Results1
- Non Reproducible Results1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Stratus CS Acute Care cTNI TestPak.IVD test for cardiac troponin I in heparinized plasma.Open, Classified
Siemens Healthcare Diagnostics Inc
Z-1673-2025 · Started Mar 31, 2025 · Posted by FDA Apr 25, 2025
Reason given: Siemens Healthcare Diagnostics Inc., is recalling their Stratus CS Acute Care cTNI TestPak, an IVD test for cardiac troponin I in heparinized plasma by removal. The reason for the recall is an increased occurrence of random non-repeatable false positive cardiac Troponin l(cTnI) results at any point during the TestPaks...
Cause as FDA categorized it: Under Investigation by firm
Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, Llc
Z-3185-2018 · Started Apr 30, 2018
Reason given: A pinhole caused by the laser printer in the aluminum sheet over the ALP reagent wells caused leakage through the pinhole. If the cartridge with leakage is used, higher measurement value as low as +12% and no higher than +20% bias may be obtained.
Cause as FDA categorized it: Process control
Z-2071-2018 · Started Mar 5, 2018
Reason given: Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.
Cause as FDA categorized it: Device Design
12 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.